Pseudomonas aeruginosa can cause life-threatening infections in immunocompromised patients. The first-line agents to treat P. aeruginosa infections are carbapenems. However, the emergence of carbapenem-resistant P. aeruginosa strains greatly compromised the effectiveness of carbapenem treatment, which makes the surveillance on their spreading and transmission important. Here we characterized the full-length genomes of two carbapenemresistant P. aeruginosa clinical isolates that are capable of producing New Delhi metallo-βlactamase-1 (NDM-1). We show that bla NDM-1 is carried by a novel integrative and conjugative element (ICE) ICE Tn4371 6385, which also carries the macrolide resistance gene msr(E) and the florfenicol resistance gene floR. By exogenously expressing msr(E) in P. aeruginosa laboratory strains, we show that Msr(E) can abolish azithromycin-mediated quorum sensing inhibition in vitro and anti-Pseudomonas effect in vivo. We conclude that ICEs are important in transmitting carbapenem resistance, and that anti-virulence treatment of P. aeruginosa infections using sub-inhibitory concentrations of macrolides can be challenged by horizontal gene transfer. | www.nature.com/commsbio P. aeruginosa NCGM2.S1 P. aeruginosa B136-33 P. aeruginosa VRFPA04 P. aeruginosa PA_D1 P. aeruginosa PASGNDM345 * * P. aeruginosa PASGNDM699 P. aeruginosa MTB-1 P. aeruginosa UCBPP-PA14 P. aeruginosa PA1 P. aeruginosa PAO1 P. aeruginosa DK2 P. aeruginosa SJTD-1 P. aeruginosa RP73 P. aeruginosa SCV20265 P. aeruginosa AES-1R P. aeruginosa ATCC27853 P. aeruginosa YL84 P. aeruginosa M18 P. aeruginosa NCTC10332 P. aeruginosa Carb01-63 P. aeruginosa LESB58 P. aeruginosa DHS01 8.0E-4 1 Fig. 1 Phylogenetic tree of PASGNDM345 and PASGNDM699 with 21 P. aeruginosa genomes. PASGNDM345 and PASGNDM699 genomes (indicated with *) were compared with 21 other P. aeruginosa genomes. Phylogenetic tree was constructed based on detected variant sites of core-genome alignment using the approximate maximum likelihood algorithm, with clade confidence estimated with SH-like support values. The scale bar shows substitutions per core-genome site. Accession numbers of genomes used to construct the phylogenetic tree are listed in Supplementary Table 2 COMMUNICATIONS BIOLOGY |
P seudomonas aeruginosa is an opportunistic pathogen which can cause life-threatening infections in immunocompromised patients 1 . It is also responsible for chronic wound infections, ventilator-associated pneumonia and chronic airway infections in cystic fibrosis and chronic obstructive pulmonary disease patients [2] [3] [4] [5] [6] . These infections are usually very difficult to eradicate and associated with high mortality rates 3, 7 .
Carbapenems such as imipenem and meropenem are the firstline agents for treating P. aeruginosa infections and the last-resort drugs for severe infections caused by other susceptible Gramnegative pathogens 8 . However, the clinical efficacy of carbapenems has been greatly compromised by the spreading of the carbapenemase New Delhi metallo-β-lactamase-1 (NDM-1), which is usually encoded and transmitted by broad-host self-conjugative plasmids in Enterobacteriaceae spp. and Acinetobacter baumannii 9 . It was later reported that bla NDM-1 was identified in P. aeruginosa isolated from North America, Europe and Asia, suggesting their prevalence worldwide [10] [11] [12] [13] [14] [15] [16] . The NDM-1-producing P. aeruginosa strains usually have high resistance to carbapenems, as well as multidrug resistance to other antibiotics, which leaves only a handful of antibiotics effective to treat their infections in clinical practice [10] [11] [12] [13] [14] [15] [16] . Therefore, it is important to develop novel treatment strategies for P. aeruginosa infections.
One strategy to treat P. aeruginosa infections is by inhibiting the production of virulence factors, which are essential for its pathogenesis. For instance, the type III secretion system and the secreted products such as elastase and exotoxin A were shown to play important roles during the colonization of P. aeruginosa in human airways 17, 18 . The secreted detergent rhamnolipid causes rapid necrosis of the host immune cells and protects bacterial cells from immune attack to facilitate the establishment of infections 19 . In P. aeruginosa, the expression of many virulence factors is under tight control of its quorum sensing systems, which can be potential targets for the design of anti-virulence drugs 20, 21 . Although several anti-quorum sensing compounds have been identified in the past, none of them has so far entered clinical trial [21] [22] [23] . On the other hand, the macrolide antibiotics such as erythromycin, azithromycin (AZM) and clarithromycin were shown to have a promising antiquorum sensing activity, which makes them ideal anti-virulence drugs for treating P. aeruginosa infections 21 . It was reported that macrolides can repress the synthesis of quorum sensing signaling molecules by interfering with the signaling pathways of RsmZ and RsmY through yet-to-be identified targets, thereby inhibiting the production of quorum sensing-regulated virulence products such as rhamnolipids and elastase in P. aeruginosa 24 . The use of macrolides as quorum sensing inhibitors has expanded our antimicrobial arsenal against P. aeruginosa infections until new and more efficient anti-virulence drugs become clinically available.
Although NDM-1-producing P. aeruginosa strains have been reported worldwide [10] [11] [12] [13] [14] [15] [16] , their complete genome information is still lacking. In this study, we sequenced the complete genomes of two NDM-producing P. aeruginosa strains. Comparative genomic analysis showed that bla NDM-1 is carried by a novel Tn4371 family integrative and conjugative element (ICE), which is a class of mobile genetic element present in genomes of a broad range of βand γproteobacteria 25 . In addition to bla NDM-1 , this element also carries the macrolide resistance gene msr(E) and the florfenicol resistance gene floR. We show that the expression of msr(E) in P. aeruginosa can abolish AZM-mediated quorum sensing inhibition in vitro and anti-Pseudomonas effect of AZM in vivo.
Results
Identification of a novel NDM-1-producing PASGNDM group. Eleven multidrug-resistant P. aeruginosa strains were previously isolated from patients in a hospital in Singapore. These strains are resistant to carbapenems, cephalosporins, aminoglycosides and fluoroquinolones, whereas they remained sensitive to polymyxin B ( Supplementary Table 1 ). To characterize the resistance mechanisms and the epidemiological link among these isolates, we sequenced their draft genomes on an Illumina MiSeq platform. We found that the 11 genomes are highly similar to each other as shown by multiple genome alignment ( Supplementary  Fig. 1 ) and carried the same sets of antibiotic resistance genes, suggesting that the 11 NDM-1-producing P. aeruginosa strains isolated in this outbreak belong to the same phylogenetic group. We therefore named this closely related P. aeruginosa group PASGNDM.
To better understand the detailed features of the PASGNDM genomes and the transmission of bla NDM-1 , we further sequenced PASGNDM345 and PASGNDM699 genomes on a Pacific Biosciences RS II platform. The PacBio sequencing reads achieved 163-and 161-fold coverages for PASGNDM345 and PASGNDM699 genomes respectively and were successfully assembled into two full-length genomes. Construction of phylogenetic tree with PASGNDM345 and PASGNDM699 genomes and other 21 P. aeruginosa full-length genomes showed that the two PASGNDM strains formed a monophyletic group (Fig. 1 ). The closest genome to the PASGNDM group in the phylogenetic tree is PA_D1 (NZ_CP012585), which belongs to a group of P. aeruginosa strains isolated from ventilator-associated pneumonia patients in China 6 .
Characterizations of PASGNDM345 and PASGNDM699 genomes. The genome of PASGNDM345 consists of a circular chromosome of 6,893,164 bp with an average GC content of 66.1%, whereas the PASGNDM699 genome is 6,985,102 bp with an average GC content of 66.0%. In total, 6503 and 6589 genes were predicted from PASGNDM345 and PASGNDM699 genomes, respectively. It was also noted that PASGNDM699 harbored several genomic islands that are not present in PASGNDM345 or the draft genomes of the other 9 PASGNDM strains ( Fig. 2 , Supplementary Fig. 1 , and Supplementary Data 1).
To identify the strain-specific regions in the PASGNDM genomes, the complete genomes of PASGNDM699 and PASGNDM345 were compared with the six genomes clustered in the same clade in the phylogenetic tree ( Fig. 1 ). Genome alignment result showed that the two PASGNDM genomes possess several regions with low sequence identity to the other six genomes (Fig. 2 ). In addition, we also predicted the genomic islands in the two PASGNDM genomes by using the Island Viewer 3 server 26 . A total of 41 and 47 genomic islands were predicted from the PASGNDM345 and PASGNDM699 genomes, respectively, which correlate well with the strain-specific regions ( Fig. 2 , and Supplementary Data 1 and 2). Most of the genes located in the genomic islands encode transposons, efflux pumps and multidrug resistance determinants (Supplementary Data 1 and 2), which may be important for the survival and nosocomial spread of the PASGNDM strains. In addition, all the nine acquired antibiotic resistance genes including bla NDM-1 are embedded in the genomic islands of PASGNDM699 and PASGNDM345 genomes ( Fig. 2 ), suggesting the importance of mobile genetic elements in the acquisition of antibiotic resistance by the PASGNDM isolates. These acquired antibiotic resistance genes are related to resistance to aminoglycosides (strA, strB and aac(3)-Id), quinolone (qnrVC1), sulfoxides (sul2), trimethoprim (dfrB5), β-lactams (bla NDM-1 ), florfenicol (floR) and macrolides (msr(E)) ( Fig. 2) . The presence of the acquired antibiotic resistance genes can largely explain the multidrug resistance of the PASGNDM strains (Supplementary Table 1 ).
Identification of a novel ICE Tn4371 6385. It was noted that bla NDM-1 is clustered together with msr(E) and floR in the same genomic island ( Fig. 2 ), suggesting that the three antibiotic resistance genes might be co-transferred into the PASGNDM genomes. Further sequence analysis revealed that the three genes are embedded in a 74.2 kb ICE-like element located between the exoY (PA2191) and hcnA (PA2193) genes in the PASGNDM699 and PASGNDM345 genomes ( Fig. 3 ). Both ends of this element are flanked by a 5′-TTTTTTGT-3′ sequence, which resembles the conserved attB site of almost all Tn4371 family ICEs 25 . It also contains the core genes conserved among the Tn4371 family ICEs, including an int integrase gene, the parB, repA and parA genes of the ICE stabilization system, and homologs to the DNA conjugative transfer machineries such as traI and traG ( Fig. 3) 25 . In addition, the integrase encoded by the int gene shared 71% identity with Int Tn4371 (AJ536756), which further proved that the ICE identified here should be a member of the Tn4371 family ICEs as suggested by Ryan et al. 25 . We therefore named this element ICE Tn4371 6385 following the nomenclature system proposed by Roberts et al. 27 .
We searched the ICE Tn4371 6385 sequence in GenBank and found that it showed similarity to a 56.4 kb ICE-like element present in Pseudomonas fluorescens UK4 genome (CP008896). Comparative sequence analysis showed that they share a common Tn4371 ICE core gene scaffold 25 , whereas their major differences are the unique accessory gene cluster following the int gene, and a 13.7 kb fragment carrying the three antibiotic resistance genes in ICE Tn4371 6385 ( Fig. 3 ). This 13.7 kb fragment is immediately flanked by 695 bp direct repeats, which share 99.87% identity (694/695) ( Fig. 3 ). Interestingly, this direct repeat sequence was also present in the ICE-like element in the P. fluorescens UK4 genome ( Fig. 3 ), whereas it showed no similarity to the existing insertion sequence elements as shown by ISfinder 28 . It is possible that the direct repeat sequences in ICE Tn4371 6385 were the result of homologous recombination between the ancestor of ICE Tn4371 6385 and a multidrug resistance plasmid, which lead to the acquisition of the 13.7 kb fragment by ICE Tn4371 6385.
We therefore present here a novel ICE Tn4371 6385 element identified in the PASGNDM genomes. ICE Tn4371 6385 carries three antibiotic resistance genes, which are bla NDM-1 , msr(E) and floR. To investigate whether bla NDM-1 is functional in P. aeruginosa, we cloned bla NDM-1 with its promoter sequence into a pME6031 vector to construct a pME6031-NDM plasmid. Transformation of pME6031-NDM into PAO1 and PA14 increases their meropenem minimal inhibitory concentration (MIC) from 1 μg/mL and 0.25 μg/ mL to > 64 μg/mL, suggesting that acquisition of bla NDM-1 by the PASGNDM strains causes their extreme resistance to carbapenems (Supplementary Table 1 ). Of note, the ICE Tn4371 6385 sequence is also present in the 9 PASGNDM draft genomes as shown in multiple genome alignment ( Supplementary Fig. 1 ). It was also noted that ICE Tn4371 6385 has partial homologous sequences in the other genomes ( Fig. 2 ). Further sequence comparison revealed that Tn4371-like elements are also present in PA14, MTB-1 and NCGM2.S1 genomes ( Supplementary Fig. 2 ), whereas none of these elements carry any antibiotic resistance genes.
Msr(E) relieves AZM-mediated quorum sensing inhibition in P. aeruginosa. Previous studies reported that sub-MIC concentrations of AZM could suppress the expression of several quorum sensing-regulated virulence factors such as elastase and rhamnolipids and the swarming motility of P. aeruginosa, probably by inhibiting its quorum sensing systems 24, 29, 30 . We therefore hypothesized that acquisition of msr(E) by P. aeruginosa could counteract the quorum sensing inhibition effect of AZM. However, to investigate the functions of msr(E) in the PASGNDM strains by gene deletion is difficult due to their multidrug resistance; hence, an alternative approach by exogenously expressing msr(E) in laboratory strains of P. aeruginosa was adopted for this purpose. We amplified the msr(E) gene together with its putative promoter region from PASGNDM699 genome and inserted the entire fragment into a pUCP18 vector to construct a pUCP18::msr(E) plasmid, in which the expression of msr (E) is solely controlled by its promoter. Transformation of pUCP18::msr(E) into P. aeruginosa strains PAO1 and PA14 increased their resistance to AZM by more than 8-fold (from 256 μg/mL to >2048 μg/mL), indicating that msr(E) can be expressed from its own promoter and is functional in P. aeruginosa. We then performed elastase production, rhamnolipid quantification and swarming motility assays with PAO1/pUCP18::msr (E) and PA14/pUCP18::msr(E) strains. The results showed that 8 μg/mL of AZM (1/32 of the AZM MIC of PAO1) reduced elastase production in both wildtype PAO1 and vector-carrying strain PAO1/pUCP18 by at least 40%, whereas the elastase produced by PAO1/pUCP18::msr(E) was not significantly affected upon AZM treatment (Fig. 4a ). We also found that 8 μg/mL of AZM reduced rhamnolipid production in both PAO1 and PAO1/pUCP18 by at least 60%, whereas PAO1/pUCP18::msr(E) produced similar levels of rhamnolipids in the presence and absence of AZM ( Fig. 4c ). In addition, the swarming motilities of PAO1 and PAO1/pUCP18 were inhibited by 4 μg/mL of AZM, under which PAO1/pUCP18::msr(E) exhibited a normal swarming phenotype (Fig. 5 ). Similar results were also obtained in the PA14 strains (Figs. 4b, d and 5), suggesting that the resistance to AZMmediated quorum sensing inhibition by Msr(E) is not strain specific. Taken together, these results clearly showed that the acquisition of msr(E) could protect P. aeruginosa from AZMmediated quorum sensing inhibition.
Msr(E) restores AZM-affected P. aeruginosa transcriptome. AZM was previously reported to affect the transcriptome of P. aeruginosa using microarray analysis 30 . To better show the effect of Msr(E) on the AZM-affected transcriptome of P. aeruginosa, we compared the gene expression profiles of PAO1/pUCP18::msr(E) in the presence and absence of 8 μg/mL AZM by total RNA sequencing. In PAO1, a total of 550 genes (~10% of PAO1 genome) were differentially expressed upon AZM treatment, of which 305 were upregulated and 245 were downregulated by more than 4-fold (Supplementary Data 3, and Fig. 6 ). We found that the upregulated genes are enriched in genes encoding ribosomal proteins, the type III secretion pathway apparatus and other defense mechanisms against AZM (infA and efp), whereas the downregulated genes include rsmY and rsmZ, the non-coding RNA products of which positively regulate quorum sensing by sequestering the translational inhibitor RsmA, pslE-I of the Psl synthesis operon, lasI of the LasI/LasR quorum sensing system, and the flgK gene the expression of which is essential for swarming motility 31 (Supplementary Data 3) . These results are consistent with findings in previous studies 21 . Surprisingly, the transcriptome of PAO1/pUCP18::msr(E) was almost not affected by AZM, for which only 6 genes were differentially expressed upon AZM treatment by more than 4-fold ( Supplementary Data 4) . These results showed that Msr(E) can protect P. aeruginosa from AZM-mediated quorum sensing inhibition by restoring the AZM-affected transcriptome.
Msr(E) abolished anti-Pseudomonas effect of AZM in vivo.
Macrolide antibiotics such as erythromycin and clarithromycin were previously shown to enhance the clearance of P. aeruginosa at the infection sites in a murine implant infection model and a murine lung infection model 33, 34 . To investigate if the expression of msr(E) in P. aeruginosa can affect the anti-Pseudomonas activity of AZM in vivo, we used the murine implant model to compare the effect of AZM treatment on PAO1 and PAO1/ pUCP18::msr(E) infections. Briefly, silicone implants precolonized with PAO1 or PAO1/pUCP18::msr(E) were inserted into the peritoneal cavity of mouse. After 12 h of incubation, mice were treated with AZM by injecting AZM solution into the peritoneal cavity, whereas the control mice were injected with the same amount of saline. The silicone implants and mice spleens were harvested at 24 h post infection to enumerate colonyforming units (CFUs) of P. aeruginosa, which were used to indicate the clearance of bacteria at infection site and the spreading of infection to other organs according to previous studies 34, 35 . We found that AZM treatment could reduce the CFUs of PAO1 residing on the silicone implants and in the mice spleens by 2.0-log and 3.8-log, respectively (Fig. 7) . By contrast, AZM treatment did not significantly affect the CFU of PAO1/ pUCP18::msr(E) recovered from either the silicone implants or the mice spleens (Fig. 7) . These results indicated that Msr(E) could confer resistance against the anti-Pseudomonas activity of AZM in vivo on P. aeruginosa.
Discussion
Tn4371 family ICEs have been previously described in a broad range of βand γ-proteobacteria isolated from both environmental and clinical settings and confer their host adaptive functions such as multidrug and heavy metal resistance, as well as the ability to metabolize specific carbon sources 25 . In addition, a Tn4371-like element from P. aeruginosa genomes has recently been characterized to carry bla SPM-1 and bcr1, suggesting that the Tn4371 family ICE is an important source of carbapenem resistance in P. aeruginosa 36 . In the current work, we identified a novel ICE Tn4371 6385 from PASGNDM genomes isolated from clinical sources. This element carries three antibiotic resistance genes including bla NDM-1 , msr(E) and floR, and retains the machinery for conjugative transfer (Fig. 3 ), suggesting that it is responsible for the transmission of these resistance genes into the PASGNDM genomes 25, 37 . However, the conjugative transfer of ICE Tn4371 6385 was not observed in mating experiments between PASGNDM699 and PAO1 or PA14 strains on agar plates (Methods). It is possible that the conjugation has extremely low efficiencies that is below our detection limit or requires specific inductive conditions 37, 38 . To the best of our knowledge, this is the first description of bla NDM-1 to be carried by ICEs. The macrolide resistance gene msr(E) were mainly identified from Gram-negative bacteria such as Enterobacteriaceae spp., Pasteurella multocida and A. baumannii [39] [40] [41] , but has not been described in P. aeruginosa before. Hence, the transmission of msr (E) by ICE Tn4371 6385 into the PASGNDM genomes led us to investigate its functional roles in P. aeruginosa. Our in vitro assays clearly showed that the exogenous expression of msr(E) in P. aeruginosa abolishes the quorum sensing inhibition activity of AZM in vitro, which in turn rescued the inhibition of elastase production, rhamnolipid production and swarming motility by sub-MIC levels of AZM ( Figs. 4 and 5 ). In addition, the acquisition of msr(E) by PAO1 almost completely restored the AZM- Supplementary Data 3 and 4) . These results demonstrate that Msr (E) could confer P. aeruginosa with resistance to AZM-mediated quorum sensing inhibition, which is an important treatment strategy for P. aeruginosa infections 42 . The transmission of msr (E) into this organism will greatly challenge the use of AZM in treating infections caused by P. aeruginosa. While we showed that Msr(E) can abolish the quorum sensing inhibition effect of AZM, the mechanism behind remains elusive. The 491-amino acid protein Msr(E) is a member of the ABC-F subfamily of adenosine triphosphate (ATP)-binding cassette proteins, which are characterized by two ATP-binding cassette domains connected by an~80 amino acid linker sequence 43, 44 . It was shown that members of the ABC-F proteins can displace antibiotics from ribosomes in vitro, which rescued translation from antibiotic-mediated inhibition 44 . In addition, ribosomal protection was shown to be sufficient to prevent AZM-mediated quorum sensing inhibition in P. aeruginosa in a previous study 45 . We therefore propose that Msr(E) can inhibit the binding of AZM with ribosomes, thereby indirectly restoring AZM-mediated quorum sensing inhibition. We are currently investigating on the mechanisms of Msr(E)-mediated macrolide resistance through structural biology approaches.
The third antibiotic resistance gene carried by ICE Tn4371 6385 is floR, which encodes an efflux pump and is the determinant for florfenicol resistance 46 . This gene was first identified in Salmonella typhimurium DT104 in 1999 and has ever since been detected in Escherichia coli and P. multocida isolated from livestock and aquaculture settings [47] [48] [49] [50] . It is possible that the emergence and spreading of floR is due to the selection by florfenicol, since this antibiotic has been extensively used in veterinary medicine, especially in aquaculture settings 49, 51 . Therefore, the carriage of floR by ICE Tn4371 6385 may associate with survival advantages under environmental conditions where florfenicol may be present 51, 52 , and hence facilitate the transmission and dissemination of bla NDM-1 and msr(E).
In conclusion, we characterized the full-length genomes of two NDM-1-producing P. aeruginosa clinical isolates, from which we identified a novel ICE Tn4371 6385 element encoding three antibiotic resistance genes. Among them, the bla NDM-1 gene is responsible for extreme resistance to carbapenems, whereas msr (E) can restore AZM-mediated quorum sensing inhibition, and floR may enhance the survival of host bacteria under florfenicol exposure. To our knowledge, we present the first description of bla NDM-1 to be carried by ICEs, and the first evidence that Msr(E) confers resistance to macrolide-mediated quorum sensing inhibition on P. aeruginosa. Our findings highlight the importance of ICEs in transmitting antibiotic resistance, and that anti-virulence treatment of P. aeruginosa infections by targeting quorum sensing through sub-inhibitory concentrations of macrolide antibiotics can be challenged by horizontal gene transfer.
Methods
Bacterial strains and plasmids. All the strains were routinely grown in Lysogeny broth (LB) or on LB plates with 1.5% agar at 37°C. The msr(E) gene with its putative promoter were amplified from PASGNDM699 genome using primers 5′-ACCGGCCAAGATAGTTGACG-3′ and 5′-AGGAAGTTCAACCGCCCTTT-3′ and ligated into the smaI site of pUCP18 53 to construct a pUCP18::msr(E) plasmid, in which msr(E) is upstream to the lac promoter of pUCP18. Similarly, bla NDM-1 and the 120 bp upstream sequence containing the promoter 54 was amplified using primers 5'-ATCTATCGATGCATGCCATGCTGTCGCACCTCATGTTT-3' and 5'-ATGACGTCGACGCGTCTGCAAGCCCAGCTTCGCATAA-3'. The PCR product was ligated in between NcoI and PstI sites of a pME6031 vector 55 to construct a pME6031-NDM plasmid, in which the expression of bla NDM-1 is solely controlled by its own promoter. Plasmids were transformed into PAO1 and PA14 by electroporation, and the transformants were selected and grown in LB supplemented with appropriate antibiotics.
Sequencing and annotation. Genomic DNA was purified using Blood and Cell Culture DNA Midi Kit (Qiagen) and sequenced on an Illumina MiSeq platform or a PacBio RS II system. The full-length genomes of PASGNDM345 and PASGNDM699 were assembled from long reads obtained from the PacBio RS II system using HGAP2 pipeline assisted with manual curation to resolve repetitive region in the assembly. The ICE Tn4371 6385 sequence and ICE-like element from P. fluorescens UK4 were uploaded to the Rapid Annotations using Subsystem Technology (RAST) server 56 for gene prediction and annotation, assisted with manual BLASTp search. Comparison of the two sequences was done by BLASTn search using EasyFig v2.2.2 57 .
Phylogenetic and comparative genomic analysis. Core-genome alignment of the P. aeruginosa genomes was performed using Parsnp v1.1.2 58 . The phylogenetic inference was carried out on the variant sites using approximate maximum likelihood algorithm by using FastTree 2 integrated in Parsnp 59 , with clade confidence estimated with SH-like supporting values. The branch length in the phylogenetic tree represent substitutions per core-genome site. Genomic islands of PASGNDM699 and PASGNDM345 were predicted by the IslandViewer 3 server 60 , and antibiotic resistance genes were predicted using the ResFinder 2.1 server 61 . Comparison of PASGNDM699 and PASGNDM345 genomes with six other fulllength P. aeruginosa genomes was done by BLASTn search using BLAST Ring Image Generator v0.95 62 , with genomic islands and antibiotic resistance genes labeled in their respective locations. Multiple sequence alignment analysis was performed by using ProgressiveMauve integrated in Mauve v2.4 63 .
Elastase and rhamnolipid quantification. Bacterial strains were grown in ABT minimal medium 64 supplemented with 5 g/L glucose and 2 g/L casamino acids (ABTGC), with or without addition of 8 μg/mL AZM (Spectrum). The supernatants of overnight culture were filter sterilized before quantification of elastase and rhamnolipid production. Elastase activity was measured using EnzCheck Elastase Assay Kit (Thermo Fisher Scientific) according to the manufacturer's instructions. The quantification of rhamnolipid was performed as previously described 65 with modifications. Briefly, rhamnolipid was extracted from 1 mL of filtered supernatants with 2 mL of diethyl ether. Then, 1 mL of the diethyl ether extract was collected, vacuum dried and re-dissolved in 50 μL of deionized water. The solution was added with 450 μL of 0.19% (w/v) orcinol dissolved in 53% H 2 SO 4 , followed by heating at 80°C for 30 min. The elastase activity and rhamnolipid production were quantified by measuring emission at 530 nm upon excitation at 485 nm and absorbance at 421 nm by using an Infinite 200 PRO system (Tecan), respectively. The results were normalized with optical density at 600 nm (OD 600 ) of the bacterial culture. Both elastase and rhamnolipid quantification assays were successfully replicated for at least three times, with measurements from distinct samples shown in the figure.
Swarming motility assay. The swarming motility of each strain was measured on 0.5% agar plates containing 8 g/L nutrient broth (Oxoid) and 5 g/L glucose 66 . Then, 1 μL of bacterial overnight culture (adjusted to OD 600 = 1) was inoculated onto the center of the plate, followed by incubation at 37°C for 12 h. The images were taken using a Gel Doc XR+ System (Bio-Rad). This experiment was successfully replicated for three times.
Transcriptomic analysis. Strains were grown in ABTGC medium at 37°C with 200 rpm shaking. Cells were harvested at mid-log phase (OD 600 = 0.6), and the total RNA was extracted using RNeasy Mini Kit (Qiagen). RNA sequencing was performed on an Illumina HiSeq 2500 platform to generate paired-end reads of 100 nt, which were trimmed and mapped to PAO1 genome (NC_002516.2) by using CLC Genomics Workbench 9.0 (Qiagen). The transcript count table was analyzed by DESeq 2 package of the R/Bioconductor by performing negative binomial test 67 . Hierarchical clustering analysis was performed to produce the heatmap for the differentially expressed genes with statistical significance (fold change>4, P < 0.05) using heatmap.2 package of the R/Bioconductor 68 .
Animal model. A murine silicone implant model was used to evaluate effects of in vivo AZM treatment on the two strains as previously described with modifications 35 . Briefly, bacterial cells were re-suspended in 0.9% NaCl to an OD 600 of 0.01. Bacteria cells were allowed to attach onto sterilized silicone tubes (length, 3 mm; inner diameter, 4 mm; outer diameter, 6 mm; Ole Dich) by incubation at 37°C
, with 110 rpm shaking for 18 h, after which the silicone tubes coated with bacteria were implanted into mouse peritoneal cavity by surgery. Treatment with AZM (10 mg per mouse, dissolved in 0.2 mL of 0.9% saline) or saline was performed by injection into the mouse peritoneal cavity 12 h after surgery. Mice were killed 24 h after surgery. Bacterial cells residing on the silicone tube and in the mouse spleen were suspended into 0.9% NaCl solution by sonication using an Elmasonic P120H (Elma, Germany; power = 50% and frequency = 37 KHz) and homogenization using a Bio-Gen PRO200 Homogenizer (Pro Scientific), respectively. CFU was quantified by serial dilution and plating on LB agar plates, and the results were shown in log CFU.
Mating experiment. The mating experiment between PASGNDM699 and both PAO1 and PA14 was performed to investigate if ICE Tn4371 6385 can transfer into other P. aeruginosa strains by conjugation. The recipient strains PAO1 and PA14 were transformed with pME6031 vector by electroporation to confer tetracycline resistance for selection. The donor and recipient strains were mixed in a 1:1 ratio and spotted onto a sterilized filter paper placed on agar plates. Conjugation experiments were performed on both rich medium (LB) and minimal medium (ABTG), and at both 25°C and 37°C. Transconjugants were selected on LB agar plates containing tetracycline (60 μg/mL) and meropenem (5 μg/mL).
Ethics. The use of clinical specimen samples was approved by Department of Laboratory Medicine, National University Hospital, Singapore, registered under the reference 2016/00856. The animal model protocols were approved by the Institutional Animal Care and Use Committee of the Nanyang Technological University, under the permit number A-0191 AZ. Animal experiments were performed in accordance to the NACLAR (National Advisory Committee for Laboratory Animal Research) Guidelines of Animal and Birds (Care and Use of Animals for Scientific Purposes) Rules by Agri-Food & Authority of Singapore (AVA).
Statistics.
All experiments were performed in at least three biologically independent replicates, with numbers of replicates indicated with "n" in figure legends. The statistical significance test method used for each experiment is also indicated in respective figure legend.
Data availability. The draft and complete genome sequences have been deposited in GenBank (www.ncbi.nlm.nih.gov/genbank/) under BioProject PRJNA381838. The complete genomes of PASGNDM699 and PASGNDM345 are CP020704 and CP020703, respectively. The genome sequencing and RNA-Seq raw reads are deposited in the NCBI Short Read Archive database (www.ncbi.nlm.nih.gov/sra) with the accession codes SRP103165 and SRP103155, respectively. All other relevant data are available from the authors upon reasonable request.
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